Wicked Lab announced on the 19th that it will showcase a pop-up store at Lotte World Mall in Jamsil until June 6 to celebrate the 5th anniversary of its product launch. At this event, attendees can sample all products, including Wicked Lab's flagship products, Biotin and Multivitamin gummy Pink gummy bears. The sale of the Asabi gummy Ruby gummy bears will also resume on-site. Wicked Lab manufactures vitamin gummies in Europe, using plant-based ingredients extracted from nature, while excluding preservatives and excipients. It is the first vitamin gummy product to receive international vegan certification and safety certification for pregnant and breastfeeding individuals called Two Safe.
Hanmi Pharmaceutical announced on the 19th that it presented three poster presentations at the World Symposium 2025 on lysosomal disorders held in San Diego, USA, from March 3 to 7 (local time), confirming the superior efficacy of the Fabry disease treatment LA-GLA (code names HM15421 and GC1134A) in improving kidney function, vascular disease, and peripheral neuropathy compared to existing treatments. Fabry disease is a progressive rare genetic disorder inherited through sex chromosomes. The company plans to enhance treatment effectiveness and convenience beyond the first-generation treatment, which requires intravenous injections at a hospital every two weeks.
SK Chemicals announced on the 19th that it has signed a joint sales agreement with Jeil Health Science for certain products of over-the-counter medications Ginexin and Trust. The medications included in the sales agreement are Ginexin F soft capsules 120 mg and Trust patches 30. Ginexin is a blood circulation improvement agent made from ginkgo leaf extract, and the soft capsule product is intended for pharmacies only. Trust is sold in packaging units of 7, 10, and 30. The Trust patches 30 were launched for patients who need to use them repeatedly. Under the sales agreement, Jeil Health Science will exclusively handle sales and marketing targeting pharmacies for the two products previously distributed through existing pharmaceutical distribution companies.
STCube announced on the 19th that it has met the criteria for designated management items with a corporate tax expense ratio of 22.7% in relation to its settlement of account results for 2024. The company attributed this achievement to the robust financial foundation it built last year and positive results in colorectal and small cell lung cancer clinical trials. Last year, STCube secured a total of 81.4 billion won in funding for clinical research. This year, it plans to accelerate clinical progress and focus on substantial new drug development for future technology exports and partnerships.
Samjin Pharm announced on the 19th that it has launched a new product, All Cleansing Balm Soft Peeling, from its vegan skincare brand Simplog. All Cleansing Balm Soft Peeling is a best-selling item from Simplog, expanding its product lineup, which is currently gaining traction on platforms like Naver official store and Olive Young. This product features a sherbet-like cleansing balm that doesn't flow, making it easy to use, and is noted for its softness at skin temperature. It melts away makeup, impurities, blackheads, and sebum, removes dead skin through the rolling of cellulose peeling particles, and provides smooth and hydrated skin without tightness through the milk-ification of the emulsified cleansing balm in water.
The National Health Insurance Corporation announced on the 19th that it will accept applications for new benefits for welfare supplies from the 13th to the 19th of next month. Welfare supplies are items that help recipients with daily living and physical activities and maintain cognitive functions. The benefits for welfare supplies were previously reviewed separately for items and products but will now be examined under a unified system starting this year. Manufacturers and importers wishing to apply for benefits for new items and products not listed as elderly long-term care insurance welfare supplies can submit applications. The corporation will review the application documents and, for those that pass, will decide on the benefit through deliberation by the Welfare Supply Benefit Evaluation Committee and the Ministry of Health and Welfare's Long-term Care Committee.